Things to Know About Axial Spondyloarthritis and Inflammatory Back Pains
Approximately 5.5 million people suffer from axial spondyloarthritis (axSpA) in America.
Axial spondyloarthritis is an incendiary form of arthritis mainly associated with pain in the lower back of the patients.
It mainly affects the joints connected to the lower spine, resulting in chronic pain in lower body parts such as the back, buttocks, and hips.
Different Stages of Axial spondyloarthritis
The term “axial spondyloarthritis” has two separate meanings. The set of different rheumatic inflammatory diseases is referred to as spondyloarthritis (SpA), whereas the term “axial” refers to the joints of the pelvis and chest.
Spondyloarthritis is different from the other types of arthritis because of the involvement of entheses (a site where tendons and ligaments get attached to the bones).
Axial spondyloarthritis can occur at any stage of life; typically, it starts between the age of 20 to 40. Mostly, women suffer from this disease, but non-radiographic AxSpA affects both men and women.
Types of Axial Spondyloarthritis
Axial spondyloarthritis (AxSpA) can be mainly classified into the following two subparts:
- Radiographic AxSpA:
This technique of AxSpA allows doctors to check the damage in the pelvic joints and spine through the help of X-rays and scan for the presence of Ankylosis in the spines.
- Non-Radiographic AxSpA:
In non-radiographic AxSpA, evidence regarding damage to different joints cannot be found with the help of an X-ray. When there is any damage in the vertebrae or joints of the patients, doctors use the non-radiographic AxSpA method, which allows them to understand the changes taking place in the patient’s body in a better way and choose the effective treatment options.
How is the market for axial spondyloarthritis evolving?
The increasing interest of the healthcare sector in curing axial spondyloarthritis has been a key factor in the growth of the global axial spondyloarthritis market.
The manufacturers operating the axial spondyloarthritis market are shifting their focus from conventional therapy to more personalized and biological therapy to improve therapeutic and patient outcomes.
Also, the key players such as Novartis International AG and Pfizer Inc. are constantly investing heavily in activities related to clinical trials to develop better drug options for treating axial spondyloarthritis.
Increasing research and investments in developing a personalized drug are the primary opportunities in the axial spondyloarthritis market.
According to BIS Research, the global axial spondyloarthritis market is expected to grow from a market value of $1,873.8 million in 2021 to $7,937.8 million by 2032 at a growth rate of 13.44% during the forecasted period 2022–2032.
Following are the key factors for increasing the demand of the global axial spondyloarthritis market:
• Increasing introduction of different new novel products
• Growing awareness of diseases related to the back and their potential dangers
• Rising activities related to research and development such as increasing investments
Common Causes Behind Axial Spondyloarthritis
Researchers and doctors still need to find the right cause of axial spondyloarthritis.
Some common causes are mentioned as follows:
- Family History and Genes
There is a high risk of getting axial spondyloarthritis if a parent has it because the genes get transmitted from the parents to their child.
- Environment
The environment plays a great role in causing diseases in humans. People living in environments containing high pollutants, infections, and toxins often have a high chance of getting affected with axial spondyloarthritis.
- Lifestyle
Certain lifestyles, such as smoking, often cause different types of diseases.
So, following a healthy lifestyle such as eating a nutritious diet and exercising is important to protect the body against AXSpA.
Exercise is the most important activity as it helps in reducing the symptoms of AXSpA, such as back pain, and strengthens the body so that it can fight against such diseases.
The Significance of Early Detection of AXSpA
The early growth of symptoms is the reason for the constant delay in analyzing the disease. Generally, people experiencing pain in their back in their twenties are unaware of the right causes of the disease.
Due to a lack of information, such people end up consulting the wrong experts such as sports medicine experts or basic physicians who may be unable to provide the required help.
Since the back pain caused due to AXSpA is different from the pain caused by over-exercising at the gym, general physicians would never be able to help in providing the required help. Thus, a rheumatologist should be consulted in such cases.
Currently, AXSpA is one of the trendy topics in the rheumatology field, which has increased the availability of several therapeutic options that common people can opt for in the future.
Conclusion
The global axial spondyloarthritis market is constantly witnessing high growth due to the increasing patients of axial spondyloarthritis. It is expected that in the future, personalized and biological therapy will allow the healthcare experts to diagnose and treat several types of chronic pains in a much more effective manner, allowing the patients to get faster relief.
